FINNENCE ▪ THE WIRE FILE
THE WIRE · № 67426
News■ Mixed
A $1B special dividend features in Indivior (INDV)'s revised merger valuation details.
KINDNews
DIRECTION■ Mixed
SOURCES1
ENTITIES2
STORY SIZESTANDALONE
FIRST SEEN2026-10-06 14:10 UTC
LAST UPDATE2026-10-06 14:10 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Special dividend and revised merger terms change deal economics for holders.
Deal terms shift value between buyer and seller
CATALYST TO WATCH
Shareholder vote on revised merger
MAIN RISK
Deal could still break or reprice
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDEarnings Season
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Lycia seeks IPO for antibody degraders as TRexBio, Retension set terms2026-10-06 08:21 UTC
Lycia seeks IPO for antibody degraders as TRexBio, Retension set terms2026-10-06 08:21 UTC
→CORRELATIONshares Healthcare
Saluda Medical Expands Access to First and Only FDA-Approved Closed-Loop Surgical Paddle Lead with Full US Commercial Release of CAP24™2026-10-06 15:27 UTC
Saluda Medical Expands Access to First and Only FDA-Approved Closed-Loop Surgical Paddle Lead with Full US Commercial Release of CAP24™2026-10-06 15:27 UTC
←CORRELATIONshares Earnings Season
IPO Market Limps, But This Offering Could Change Everything2026-10-05 20:06 UTC
IPO Market Limps, But This Offering Could Change Everything2026-10-05 20:06 UTC
←CORRELATIONshares Earnings Season
At $18 a share, Accelevation (ACCV) holders sold IPO stock; another holder distributed shares for free.2026-10-06 01:21 UTC
At $18 a share, Accelevation (ACCV) holders sold IPO stock; another holder distributed shares for free.2026-10-06 01:21 UTC
←CORRELATIONshares Healthcare
Lycia seeks IPO for antibody degraders as TRexBio, Retension set terms2026-10-06 08:21 UTC
Lycia seeks IPO for antibody degraders as TRexBio, Retension set terms2026-10-06 08:21 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.